QLT

Covid-19 Multi-Analyte Respiratory Panel Nucleic Acid Devices

产品代码
QLT
器械名称
Covid-19 Multi-Analyte Respiratory Panel Nucleic Acid Devices
管理类别
第 N 类(Not Classified)
FDA 专业组
Unknown
上市路径
EUA - Emergency Use Authorization

FDA 分类定义

Multi-analyte nucleic acid-based in vitro diagnostic devices for the simultaneous qualitative detection and differentiation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that causes COVID-19, and common respiratory microorganisms in human respiratory and/or acceptable clinical specimens collected from individuals suspected of respiratory viral infection consistent with COVID-19 by a healthcare provider. Results should not be used as the sole basis for diagnosis, treatment or other patient management decisions and must be combined with clinical observations, patient history, and/or epidemiological information.

定义原文来自 FDA 器械分类库,属美国联邦政府作品(公有领域)。

FDA 官方分类页: QLT
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。